amgen glp-1 drug could threaten Novo Nordisk, Eli Lilly weight loss dominance GLP-1 Medications for Weight Loss:
Description
Albeit, in a manner some may find surprising

Characteristics of elderly patients initiating sitagliptin or non-DPP-4-inhibitor oral antihyperglycemic agents: analysis of a cross-sectional US claims database

doi: 10.1136/jmedgenet-2011-100727 222 ZhangYHoKKeatonJMHartzelDNDayFJusticeAEet al

[DOI] [PubMed] [Google Scholar] 252.Christensen L.W., Kuhre R.E., Janus C., Svendsen B., Holst J.J

Clin Schizophr Relat Psychoses

An examination of the divergent spatiotemporal signaling of GLP-1R versus GIPR in pancreatic beta cells
